Head-to-head · Cost-Efficiency Index
Wisp vs Allara Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Wisp
Cost-first shoppers who want branded injectables plus a sublingual semaglutide alternative.
Visit WispAllara Health
Cost-first shoppers who want insured patients who want women's hormonal-health specialists to manage a GLP-1 prescription, not shoppers pricing the drug itself.
Visit Allara HealthThe verdict
Wisp takes it, leading the Cost-Efficiency Index 63 to 62. Wisp (hellowisp.com) is a US telehealth provider whose weight care vertical offers brand-name Wegovy, Zepbound, and Saxenda alongside a compounded sublingual semaglutide drops formulation at $225/month. Allara Health still earns a C — Cost-first shoppers who want insured patients who want women's hormonal-health specialists to manage a GLP-1 prescription, not shoppers pricing the drug itself.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Wisp.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Wisp | Allara Health |
|---|---|---|
| Cost-Efficiency Index | 63/100 | 62/100 |
| Semaglutide / mo | $225/mo (compounded oral) | $149/mo (plus a separate fee, brand-name) |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | $2,700 | $1,788 |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Yes | Yes |
| Rank here | #202 | #204 |
Wisp
63/100Where the value is
- Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
- LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
- Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary
The tradeoffs
- The $99/mo tirzepatide figure is a consultation-and-care subscription, not the medication: Zepbound is filled at a pharmacy of your choice at its own cost, which Wisp does not publish
- The compounded semaglutide option is sublingual drops, which Wisp itself describes as less effective than injection
Allara Health
62/100Where the value is
- In-network with major insurers (Aetna, Blue Cross Blue Shield/Anthem/Carefirst, Cigna, United Healthcare/Oxford/UMR, GEHA), which can make branded GLP-1s cheaper than any cash-pay compounded option for covered patients
- Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound) rather than unapproved compounded preparations
- Board-certified OB-GYNs, endocrinologists, and Registered Dietitians on a women's-health-specialized platform
The tradeoffs
- No GLP-1 medication price is published anywhere on the site — the $149/mo figure is a visit/membership fee only, and actual drug cost depends entirely on insurance or is undisclosed for self-pay
- Not a general low-cost GLP-1 shopping option — the platform is built around women's hormonal/PCOS specialty care, with GLP-1 as one treatment among many
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.